AZTR
Azitra Inc · AMEX
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website azitrainc.com
- Employees(FY) 10
- ISIN US05479L1044
Performance
-26.76%
1W
-9.9%
1M
-27.35%
3M
-88.66%
6M
-80.22%
YTD
-96.32%
1Y
Profile
Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.
Technical Analysis of AZTR 2024-05-10
Overview:
In analyzing the technical indicators for AZTR over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming trading days.
Trend An...
Recent News & Updates
- 2024-05-16 20:00
- 2024-05-09 20:00
- 2024-05-09 05:00
- 2024-04-22 04:30
- 2024-04-18 04:15
- 2024-03-15 04:15
- 2024-02-16 03:05
Azitra, Inc. Announces Closing of Public Offering(Yahoo Finance)
- 2024-02-13 09:09
Azitra, Inc. Announces Pricing of Public Offering(Yahoo Finance)
- 2024-01-15 20:00
- 2024-01-02 20:00
- 2023-11-14 03:30
- 2023-10-15 20:00
Azitra to Present at the ThinkEquity Conference(Yahoo Finance)
- 2023-08-28 20:00
- 2023-08-14 04:05
- 2023-07-19 04:05
- 2023-07-11 04:05
- 2023-06-21 06:46
Azitra, Inc. Announces Closing of Initial Public Offering(Yahoo Finance)
- 2023-06-15 07:04
Azitra, Inc. Announces Pricing of Initial Public Offering(Yahoo Finance)
Page 1 of 1
previousnext